Reports preliminary Q4 adjusted EBITDA loss $10.7M. The company said, “Preliminary total revenue was $10.9 million for the fourth quarter of 2023 compared to revenue of $15.3 million for the fourth quarter of 2022. While PHA revenue increased by $0.9 million in the quarter as compared with the prior year quarter, loss of shipments to customers affected by the conflict in Ukraine reduced the quarter-over-quarter PLA revenue by $4.9 million, leading to a net reduction in product revenue of $4.0 million.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DNMR:
- Danimer Scientific options imply 17.3% move in share price post-earnings
- Danimer Scientific options imply 12.5% move in share price post-earnings
- Danimer Scientific options imply 28.6% move in share price post-earnings
- Danimer Scientific expands Rinnovo demonstration plant capacity
- Danimer Scientific receives continued listing standard notice from NYSE
